相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
Volker Heinemann et al.
BMC CANCER (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-IR
Bhaumik B. Patel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Role of curcumin in cancer therapy
Shishir Shishodia et al.
CURRENT PROBLEMS IN CANCER (2007)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines
Shahar Lev-Ari et al.
CANCER INVESTIGATION (2007)
Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation
Eun Mi Jung et al.
CARCINOGENESIS (2006)
Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells
Sanaz Khanbolooki et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells
Sudha Reddy et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects
ME Egan et al.
SCIENCE (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil
JY Koo et al.
JOURNAL OF MEDICINAL FOOD (2004)
Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
RA Sharma et al.
CLINICAL CANCER RESEARCH (2004)
Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model
T Devasena et al.
PHARMACOLOGICAL RESEARCH (2003)
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
A Ashkenazi
NATURE REVIEWS CANCER (2002)
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
SE Chuang et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Chemotherapeutic potential of curcumin for colorectal cancer
DP Chauhan
CURRENT PHARMACEUTICAL DESIGN (2002)
Microsatellite instability as a marker in predicting metachronous multiple colorectal carcinomas after surgery - A cohort-like study
K Shitoh et al.
DISEASES OF THE COLON & RECTUM (2002)
Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells
A Goel et al.
CANCER LETTERS (2001)
分享论文
